Dendritic cell nuclear protein 1 (DCANP1)

Dendritic cell nuclear protein 1 (DCANP1, also known as DCNP1 and C5orf20) is an intronless gene encoding a nuclear protein specifically expressed in dendritic cells, which are antigen-presenting cells essential for activating naïve T cells to initiate immune responses[1][5][7]. The protein is localized primarily in the perinuclear region and can bind to and transactivate the promoter region of the corticotropin-releasing hormone (CRH) gene, which is involved in stress responses[1][4][11]. A particular genetic variant (A/T allele causing premature stop) has been associated with increased prevalence of major depressive disorder in humans[1][4][7]. There is no evidence of DCANP1 being a validated therapeutic target (e.g. receptor, enzyme) or having any known drug interactions. Its specific functions in dendritic cells are not fully characterized, but current data point to roles in gene regulation and immune system signaling. The gene is also known as Chromosome 5 Open Reading Frame 20 (C5orf20)[1][11]. Notes: - DCANP1 is not considered a canonical therapeutic target, such as a receptor, enzyme, or transporter. - The terminology and abundance of aliases may create confusion, but the molecule is best referred to as "Dendritic cell nuclear protein 1 (DCANP1)". - Some ambiguity exists in literature about its mechanistic roles, and there is limited functional and therapeutic characterization available[1][4][7][8]. - No known biomarkers, safety concerns, or pharmacological mechanisms are reported in the current scientific literature.

Other names

Dendritic cell nuclear protein 1Dendritic cell-associated nuclear protein 1DCANP1DCNP1C5orf20Chromosome 5 Open Reading Frame 20Dendritic Cell Associated Nuclear ProteinDendritic Cell Nuclear Protein-1